Core Viewpoint - The renewal of the exclusive agency agreement between Gaoshi Medical and Schwind eye-tech-solutions GmbH signifies a long-term strategic partnership that enhances Gaoshi Medical's competitive advantage in the refractive surgery equipment market in China [1] Group 1: Company Overview - Gaoshi Medical's subsidiary, Shanghai Gaoshi Mingwang Medical Equipment Co., Ltd., has recently renewed its exclusive agency agreement with Schwind eye-tech-solutions GmbH for the Chinese market, including mainland China, Hong Kong, and Macau [1] - The partnership with Schwind, a key supplier since 2009, has lasted over 16 years, indicating a stable and mutually beneficial relationship [1] Group 2: Industry Context - Schwind eye-tech-solutions GmbH has over 30 years of experience in developing ophthalmic refractive surgery equipment and is recognized as a global leader in excimer laser and femtosecond laser technology [1] - Schwind's products, including the ATOS personalized navigation femtosecond and AMARIS excimer series, are known for their innovation, precision, and stability, and are widely used in over 100 countries, receiving high recognition from refractive surgery professionals globally [1] - The renewal of the agency agreement is expected to deepen the cooperative relationship and create more potential growth opportunities for Gaoshi Medical, aligning with the overall interests of the company and its shareholders [1]
高视医疗(02407.HK)与德国SCHWIND公司续签独家代理协议